DBD DIEBOLD NIXDORF INC revenue, earnings and financials

For the quarter ended June 30, 2026, DIEBOLD NIXDORF INC reported revenue of $931M (up 1.7% from a year earlier), net income of $15.5M and diluted EPS of $0.44; over the last four quarters revenue was $3.87B and net income $111M; for the fiscal year ended December 2025 revenue was $3.81B, up 1.5% on the year before.

DBD annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $3.81B, gross profit $961M, operating income $242M, net income $94.6M (margin 2.5%), EPS $2.54
• Fiscal year ended Dec 2024: revenue $3.75B, gross profit $920M, operating income $182M, net income −$16.5M (margin -0.4%), EPS −$0.44
• Fiscal year ended Dec 2022: revenue $3.46B, gross profit $757M, operating income −$212M, net income −$581M (margin -16.8%), EPS −$7.36
• Fiscal year ended Dec 2021: revenue $3.91B, gross profit $1.04B, operating income $137M, net income −$78.8M (margin -2.0%), EPS −$1.01

DBD quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $931M (up 1.7% year over year), net income $15.5M, EPS $0.44
• Quarter ended Mar 31, 2026: revenue $892M (up 6.0% year over year), net income $5.00M, EPS $0.14
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.10B (up 11.7% year over year), net income $49.6M, EPS $1.32
• Quarter ended Sep 30, 2025: revenue $945M (up 2.0% year over year), net income $41.1M, EPS $1.11
• Quarter ended Jun 30, 2025: revenue $915M (down 2.6% year over year), net income $12.2M, EPS $0.33
• Quarter ended Mar 31, 2025: revenue $841M (down 6.1% year over year), net income −$8.30M, EPS −$0.22
• Quarter ended Dec 31, 2024 (from the annual report): revenue $989M, net income $5.60M, EPS $0.15
• Quarter ended Sep 30, 2024: revenue $927M (up 3.5% year over year), net income −$22.4M, EPS −$0.60
• Quarter ended Jun 30, 2024: revenue $940M (up 1.9% year over year), net income $14.9M, EPS $0.40
• Quarter ended Mar 31, 2024: revenue $895M (up 4.3% year over year), net income −$14.6M, EPS −$0.39
• Quarter ended Sep 30, 2023: revenue $895M (up 10.5% year over year), net income −$8.90M, EPS −$0.24
• Quarter ended Jun 30, 2023: revenue $922M (up 8.3% year over year), net income −$677M, EPS −$8.46
• Quarter ended Mar 31, 2023: revenue $858M (up 3.4% year over year), net income −$111M, EPS −$1.40
• Quarter ended Dec 31, 2022 (from the annual report): revenue $969M (down 8.6% year over year), net income −$149M, EPS n/a
• Quarter ended Sep 30, 2022: revenue $810M (down 15.4% year over year), net income −$49.8M, EPS −$0.63
• Quarter ended Jun 30, 2022: revenue $852M (down 9.7% year over year), net income −$199M, EPS n/a
• Quarter ended Mar 31, 2022: revenue $830M (down 12.1% year over year), net income −$183M, EPS n/a
• Quarter ended Dec 31, 2021 (from the annual report): revenue $1.06B, net income −$38.3M, EPS −$0.49
• Quarter ended Sep 30, 2021: revenue $958M, net income −$2.10M, EPS −$0.03
• Quarter ended Jun 30, 2021: revenue $944M, net income −$30.3M, EPS −$0.39

DBD cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $301M, share buybacks $131M
• Fiscal year ended Dec 2024: operating cash flow $149M, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow −$388M, share buybacks $7.80M
• Fiscal year ended Dec 2021: operating cash flow $123M, share buybacks $7.70M

DBD balance sheet

• Jun 30, 2026: cash n/a, total assets $3.74B, total liabilities $2.76B, shareholders' equity $969M, long-term debt $943M
• Mar 31, 2026: cash $359M, total assets $3.83B, total liabilities $2.80B, shareholders' equity $1.02B, long-term debt $939M
• Dec 31, 2025: cash $369M, total assets $3.85B, total liabilities $2.75B, shareholders' equity $1.10B, long-term debt $939M
• Sep 30, 2025: cash $246M, total assets $3.72B, total liabilities $2.61B, shareholders' equity $1.11B, long-term debt $934M
• Jun 30, 2025: cash $279M, total assets $3.74B, total liabilities $2.63B, shareholders' equity $1.10B, long-term debt $931M
• Mar 31, 2025: cash $307M, total assets $3.63B, total liabilities $2.63B, shareholders' equity $984M, long-term debt $929M
• Dec 31, 2024: cash $296M, total assets $3.54B, total liabilities $2.61B, shareholders' equity $930M, long-term debt $927M
• Sep 30, 2024: cash $251M, total assets $3.90B, total liabilities $2.83B, shareholders' equity $1.07B

What is DBD's revenue?

DIEBOLD NIXDORF INC reported $3.87B of revenue over its last four quarters, through June 30, 2026.

Is DBD profitable?

Yes. DIEBOLD NIXDORF INC earned $111M over the last four quarters.

What is DBD's EPS?

Diluted earnings per share over the last four quarters were $3.01; $0.44 in the latest quarter.

DBD ownership and insider trades · All stocks